These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 22940767

  • 1. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, Camus M, Devroey P, Tournaye H.
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [Abstract] [Full Text] [Related]

  • 2. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG, Sfontouris IA, Venetis CA, Lainas GT, Zorzovilis IZ, Tarlatzis BC, Kolibianakis EM.
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [Abstract] [Full Text] [Related]

  • 3. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
    Polyzos NP, De Vos M, Corona R, Vloeberghs V, Ortega-Hrepich C, Stoop D, Tournaye H.
    Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
    [Abstract] [Full Text] [Related]

  • 4. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.
    Busnelli A, Papaleo E, Del Prato D, La Vecchia I, Iachini E, Paffoni A, Candiani M, Somigliana E.
    Hum Reprod; 2015 Feb; 30(2):315-22. PubMed ID: 25432927
    [Abstract] [Full Text] [Related]

  • 5. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B.
    Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
    [Abstract] [Full Text] [Related]

  • 6. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589
    [Abstract] [Full Text] [Related]

  • 7. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb 01; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 8. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
    Polyzos NP, Nwoye M, Corona R, Blockeel C, Stoop D, Haentjens P, Camus M, Tournaye H.
    Reprod Biomed Online; 2014 Apr 01; 28(4):469-74. PubMed ID: 24581984
    [Abstract] [Full Text] [Related]

  • 9. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.
    Hum Reprod; 2013 Dec 01; 28(12):3236-46. PubMed ID: 24166594
    [Abstract] [Full Text] [Related]

  • 10. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A, Tsur A, Haas J, Yerushalmi GM, Hourvitz A, Machtinger R, Orvieto R.
    Fertil Steril; 2014 Jun 01; 101(6):1624-8. PubMed ID: 24680364
    [Abstract] [Full Text] [Related]

  • 11. In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option?
    Quinquin M, Mialon O, Isnard V, Massin N, Parinaud J, Delotte J, Bongain A.
    Fertil Steril; 2014 Dec 01; 102(6):1596-601. PubMed ID: 25256936
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J, Schertz J, ESPART Study Investigators‡.
    Hum Reprod; 2017 Mar 01; 32(3):544-555. PubMed ID: 28137754
    [Abstract] [Full Text] [Related]

  • 13. Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
    Santos-Ribeiro S, Polyzos NP, Haentjens P, Smitz J, Camus M, Tournaye H, Blockeel C.
    Hum Reprod; 2014 Aug 01; 29(8):1698-705. PubMed ID: 24939956
    [Abstract] [Full Text] [Related]

  • 14. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study.
    Courbiere B, Decanter C, Bringer-Deutsch S, Rives N, Mirallié S, Pech JC, De Ziegler D, Carré-Pigeon F, May-Panloup P, Sifer C, Amice V, Schweitzer T, Porcu-Buisson G, Poirot C, French Study Group for Ovarian and Testicular Cryopreservation (GRECOT).
    Hum Reprod; 2013 Sep 01; 28(9):2381-8. PubMed ID: 23832792
    [Abstract] [Full Text] [Related]

  • 15. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
    Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG.
    Hum Reprod; 2015 Mar 01; 30(3):684-91. PubMed ID: 25586787
    [Abstract] [Full Text] [Related]

  • 16. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, van Golde RJT, Hoek A, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Torrance HL, Broekmans FJM, OPTIMIST study group.
    Hum Reprod; 2019 Jun 04; 34(6):1030-1041. PubMed ID: 31125412
    [Abstract] [Full Text] [Related]

  • 17. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
    Bosdou JK, Venetis CA, Tarlatzis BC, Grimbizis GF, Kolibianakis EM.
    Hum Reprod; 2019 Mar 01; 34(3):491-505. PubMed ID: 30689865
    [Abstract] [Full Text] [Related]

  • 18. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE, van der Houwen LE, Overbeek A, Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, Renckens CN, Bernardus RE, Schats R, Homburg R, Hompes PG, Lambalk CB.
    Hum Reprod; 2013 Oct 01; 28(10):2804-12. PubMed ID: 23838159
    [Abstract] [Full Text] [Related]

  • 19. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC.
    Hum Reprod; 2015 Feb 01; 30(2):432-40. PubMed ID: 25492411
    [Abstract] [Full Text] [Related]

  • 20. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC, Yarali H, Vuong LN, Carvalho JF, Özbek İY, Polat M, Le HL, Pham TD, Ho TM, Humaidan P, Alviggi C.
    Hum Reprod; 2021 Jul 19; 36(8):2157-2169. PubMed ID: 34179973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.